Compare Stocks

Date Range: 

 PraxsynSpotlight InnovationSienna BiopharmaceuticalsSophiris BioAnthera Pharmaceuticals
SymbolOTCMKTS:PXYNOTCMKTS:STLTOTCMKTS:SNNAQOTCMKTS:SPHSOTCMKTS:ANTH
Price Information
Current Price$0.00$0.01$0.03$0.02N/A
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.60.50.50.10.5
Analysis Score0.00.00.00.00.0
Community Score3.12.62.50.02.5
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.60.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$763,000.00$343,000.00$607,000.00$709,000.00$1.05 million
Beta-1.34-105.241.731.862.19
Average Volume761,91618,173119,761333,504169,694
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/AN/AN/AN/AN/A
Price / BookN/AN/AN/AN/AN/A
Profitability
Net IncomeN/AN/A$-73,470,000.00$-6,780,000.00N/A
EPSN/AN/AN/AN/AN/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E Ratio∞∞∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/AN/AN/AN/AN/A
Quick RatioN/AN/AN/AN/AN/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/A27.20%4.50%2.08%
Miscellaneous
Employees66413621
Shares Outstanding847.94 million34.29 million22.89 million35.55 million13.85 million
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
SourceHeadline
Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Short Interest UpdateAnthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Short Interest Update
americanbankingnews.com - April 28 at 2:56 AM
Systemic Lupus Erythematosus (SLE) Drugs Market 2021 Technological Innovations, In-depth Qualitative Assessment and Industry Value Chain to 2028Systemic Lupus Erythematosus (SLE) Drugs Market 2021 Technological Innovations, In-depth Qualitative Assessment and Industry Value Chain to 2028
marketwatch.com - April 24 at 1:07 AM
Anthera Pharmaceuticals (OTCMKTS:ANTH) Stock Crosses Above Two Hundred Day Moving Average of $0.05Anthera Pharmaceuticals (OTCMKTS:ANTH) Stock Crosses Above Two Hundred Day Moving Average of $0.05
americanbankingnews.com - April 24 at 12:58 AM
Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Sees Significant Growth in Short InterestAnthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Sees Significant Growth in Short Interest
americanbankingnews.com - April 14 at 12:22 PM
Hemoglobinopathies Market Statistics, Size, Share, Regional Analysis by Key Players | Industry Forecast to 2027Hemoglobinopathies Market Statistics, Size, Share, Regional Analysis by Key Players | Industry Forecast to 2027
marketwatch.com - March 27 at 11:07 PM
Exocrine Pancreatic Insufficiency Market Research Report: Recent Trends, Top Players, Comprehensive Evaluation of Business Share Forecast to 2025Exocrine Pancreatic Insufficiency Market Research Report: Recent Trends, Top Players, Comprehensive Evaluation of Business Share Forecast to 2025
marketwatch.com - March 24 at 3:13 AM
Global Arteriosclerosis Therapeutics Market 2020 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2025Global Arteriosclerosis Therapeutics Market 2020 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2025
marketwatch.com - March 10 at 9:46 PM
Vasculitis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Vasculitis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - February 24 at 10:28 PM
Global Systemic Lupus Erythematous SLE Drug Market 2020 Competitive Scenario, Trending News, Potential Players and Dynamic Progression till 2025Global Systemic Lupus Erythematous SLE Drug Market 2020 Competitive Scenario, Trending News, Potential Players and Dynamic Progression till 2025
marketwatch.com - February 10 at 8:18 AM
AM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following MMM Holdings, LLC Acquisition AnnouncementAM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following MMM Holdings, LLC Acquisition Announcement
finance.yahoo.com - February 5 at 10:11 AM
Gaucher Disease Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Gaucher Disease Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - January 14 at 7:46 PM
Covid-19 impact: Systemic Lupus Erythematous SLE Drug Market to grow at a much faster rate beyond 2020| Financial Analysis and ForecastCovid-19 impact: Systemic Lupus Erythematous SLE Drug Market to grow at a much faster rate beyond 2020| Financial Analysis and Forecast
apnews.com - January 13 at 8:23 AM
Global Hemoglobinopathy Treatment Drug Market 2020 Growth Parameters, Competitive Landscape Outlook and COVID-19 Impact Prediction 2025Global Hemoglobinopathy Treatment Drug Market 2020 Growth Parameters, Competitive Landscape Outlook and COVID-19 Impact Prediction 2025
marketwatch.com - January 4 at 2:14 AM
Systemic Lupus Erythematosus Treatment Market Incredible Possibilities, Growth Analysis and Forecast To 2026Systemic Lupus Erythematosus Treatment Market Incredible Possibilities, Growth Analysis and Forecast To 2026
marketwatch.com - December 24 at 6:26 AM
Global Exocrine Pancreatic Insufficiency MarketGlobal Exocrine Pancreatic Insufficiency Market
openpr.com - December 15 at 11:50 PM
Daniel SpiegelmanDaniel Spiegelman
businessnews.com.au - November 18 at 11:42 PM
Global Gaucher Disease Treatment Market 2020 Comprehensive Research Methodology, Regional Study and Business Operation Data Analysis by 2026Global Gaucher Disease Treatment Market 2020 Comprehensive Research Methodology, Regional Study and Business Operation Data Analysis by 2026
marketwatch.com - November 16 at 2:12 PM
Global Hemoglobinopathy Treatment Drug Market 2020 Comprehensive Industry and Vendor Landscape 2025Global Hemoglobinopathy Treatment Drug Market 2020 Comprehensive Industry and Vendor Landscape 2025
marketwatch.com - November 13 at 12:41 AM
Exocrine Pancreatic Insufficiency Market : Segments Worth Observing Aiding Growth Factors | Axcan, Aptalis Pharma Inc.Exocrine Pancreatic Insufficiency Market : Segments Worth Observing Aiding Growth Factors | Axcan, Aptalis Pharma Inc.
marketwatch.com - November 7 at 7:55 AM
Global Cutaneous Lupus Erythematosus (CLE) Treatment Market 2020 Analysis of Key Trend, Industry Dynamics and Future Growth 2025Global Cutaneous Lupus Erythematosus (CLE) Treatment Market 2020 Analysis of Key Trend, Industry Dynamics and Future Growth 2025
marketwatch.com - November 4 at 7:25 PM
Global Celiac Drugs Market Business Opportunities, Leading Players Updates And Forecast(2020-2029)Global Celiac Drugs Market Business Opportunities, Leading Players Updates And Forecast(2020-2029)
apnews.com - October 1 at 8:12 AM
Celiac Drugs Market Demands, Competitive Insights And Precise Outlook 2020-2026Celiac Drugs Market Demands, Competitive Insights And Precise Outlook 2020-2026
marketwatch.com - August 28 at 4:21 AM
Vasculitis Treatment Market 2020 Top Manufacturers, Analysis, Industry Size, Future Trends and Industry Growth Research Report 2025Vasculitis Treatment Market 2020 Top Manufacturers, Analysis, Industry Size, Future Trends and Industry Growth Research Report 2025
marketwatch.com - August 26 at 2:58 PM
Celiac Disease Drug Market 2020 Analysis and Industry Outlook 2026Celiac Disease Drug Market 2020 Analysis and Industry Outlook 2026
marketwatch.com - August 22 at 8:13 AM
ANTH.PK - Anthera Pharmaceuticals Inc Profile | ReutersANTH.PK - Anthera Pharmaceuticals Inc Profile | Reuters
reuters.com - August 16 at 9:47 AM
DateCompanyBrokerageAction
10/21/2019Sophiris BioHC WainwrightSet Price Target
6/19/2019Sophiris BioMaxim GroupSet Price Target
3/13/2019Sophiris BioPiper Jaffray CompaniesLower Price Target
(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.